Evidence for treating malaria with artemisinin-based combination therapy in the first trimester of pregnancy
- PMID: 32546326
- PMCID: PMC10186202
- DOI: 10.1016/S1473-3099(20)30131-6
Evidence for treating malaria with artemisinin-based combination therapy in the first trimester of pregnancy
Erratum in
-
Correction to Lancet Infectious Diseases 2020; published online April 29. https://doi.org/10.1016/ S1473-3099(20)30064-5.Lancet Infect Dis. 2020 Jul;20(7):e148. doi: 10.1016/S1473-3099(20)30370-4. Epub 2020 May 5. Lancet Infect Dis. 2020. PMID: 32595044 No abstract available.
Conflict of interest statement
We declare no competing interests.
Comment on
-
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.Lancet Infect Dis. 2020 Aug;20(8):943-952. doi: 10.1016/S1473-3099(20)30064-5. Epub 2020 Apr 29. Lancet Infect Dis. 2020. PMID: 32530424 Free PMC article.
References
-
- Saito M, Mansoor R, Kennnon K, et al. Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis. Lancet Infect Dis 2020; published online April 29. 10.1016/S1473-3099(20)30064-5. - DOI - PMC - PubMed
-
- Maxwell JP. The use of quinine during pregnancy, labour and the puerperium. J Trop Med Hyg 1908; 11: 191–94.
-
- WHO. Guidelines for the treatment of malaria, 3rd edn. Geneva: World Health Organization, 2015. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
